Epoch Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Epoch Pharmaceuticals, Inc..The latest application filed is for "fluorescent quenching detection reagents and methods".

Company Profile

0.17.3

Epoch Pharmaceuticals, Inc. - Bethell WA
EPOCH PHARMACEUTICALS, INC. - 12277 134th Court NE, Suite 110 Redmond WA
Epoch Pharmaceuticals, Inc. - Redmond WA
Epoch Pharmaceuticals, Inc. - Bothell WA
Epoch Pharmaceuticals, Inc. - Washington DC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified oligonucleotides for mismatch discrimination Grant 6,949,367 - Dempcy , et al. September 27, 2	2005-09-27
Fluorescent quenching detection reagents and methods App 20040191796 - Reed, Michael W. ; et al.	2004-09-30
Fluorescent quenching detection reagents and methods Grant 6,727,356 - Reed , et al. April 27, 2	2004-04-27
Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders App 20040058322 - Hedgpeth, Joel ; et al.	2004-03-25
Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders Grant 6,492,346 - Hedgpeth , et al. December 10, 2	2002-12-10
Oligonucleotides containing pyrazolo[3,4-d]pyrimidines for hybridization and mismatch discrimination Grant 6,485,906 - Meyer, Jr. , et al. November 26, 2	2002-11-26
Fluorescent quenching detection reagents and methods App 20020155484 - Reed, Michael W. ; et al.	2002-10-24
Methods and compositions to facilitate D-loop formation by oligonucleotides Grant 6,312,925 - Meyer, Jr. , et al. November 6, 2	2001-11-06
Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders Grant 6,312,894 - Hedgpeth , et al. November 6, 2	2001-11-06
Oligonucleotides including pyrazolo[3,4-D]pyrimidine bases, bound in double stranded nucleic acids Grant 6,143,877 - Meyer , et al. November 7, 2	2000-11-07
Targeted mutagenesis in living cells using modified oligonucleotides Grant 6,136,601 - Meyer, Jr. , et al. October 24, 2	2000-10-24
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination Grant 6,127,121 - Meyer, Jr. , et al. October 3, 2	2000-10-03
Covalently linked oligonucleotide minor grove binder conjugates Grant 6,084,102 - Kutyavin , et al. July 4, 2	2000-07-04
Targeted mutagenesis in living cells using modified oligonucleotides Grant 5,935,830 - Meyer, Jr. , et al. August 10, 1	1999-08-10
Selective binding complementary oligonucleotides Grant 5,912,340 - Kutyavin , et al. June 15, 1	1999-06-15
Crosslinking oligonucleotides Grant 5,849,482 - Meyer, Jr. , et al. December 15, 1	1998-12-15
Cross-linking oligonucleotides Grant 5,824,796 - Petrie , et al. October 20, 1	1998-10-20
Covalently linked oligonucleotide minor grove binder conjugates Grant 5,801,155 - Kutyavin , et al. September 1, 1	1998-09-01
Oligonucleotide-cyclopropapyrroloindole conjugates as sequence specific hybridization and crosslinking agents for nucleic acids Grant 5,659,022 - Kutyavin , et al. August 19, 1	1997-08-19
Oligonucleotides containing n-methyl thiolated bases having antiviral activity Grant 5,652,359 - Meyer, Jr. , et al. July 29, 1	1997-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.